Eli Lilly and Company delivered solid FY2025 results, with revenue of $65.18B and net income of $20.64B. The company continues to demonstrate resilience across its core business segments, supported by Drug Manufacturers - General demand tailwinds and disciplined cost management. Free cash flow gener
Access the complete analysis, financial model, price target breakdown, and risk factors.
Read Full Report →2 free reads per day · No credit card required